BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4717914)

  • 1. 'Immune' RNA-mediated transfer of delayed skin reactivity in patients with Hodgkin's disease.
    Han T
    Clin Exp Immunol; 1973 Jun; 14(2):213-7. PubMed ID: 4717914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive transfer of cell-mediated immunity to tuberculin using RNA from tuberculin-sensitive subjects.
    Han T; Pauly JL; Mittelman A
    Immunology; 1975 Jan; 28(1):127-32. PubMed ID: 1116867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of the transfer factor].
    Mutz I; Humphrey GB
    Wien Klin Wochenschr; 1973 May; 85(20):357-60. PubMed ID: 4574399
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunity in Hodgkin's disease.
    Leibowitz S
    Guys Hosp Rep; 1966; 115(3):341-57. PubMed ID: 5334964
    [No Abstract]   [Full Text] [Related]  

  • 5. [Delayed allergy in Hodgkin's disease].
    Tortoli V
    Folia Allergol (Roma); 1967; 14(1):56-66. PubMed ID: 5600234
    [No Abstract]   [Full Text] [Related]  

  • 6. Skin reactivity to bacterial antigens in Hodgkin's disease.
    Rasiewicz W; Kardaszewicz E
    Pol Med J; 1969; 8(5):1203-8. PubMed ID: 5383935
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on delayed hypersensitivity of patients with Hodgkin's disease during remission.
    Petrov M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(1):35-9. PubMed ID: 50967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invited discussion: kinetic approach to the study of cell-mediated immunity in Hodgkin's disease.
    Hersh EM
    Natl Cancer Inst Monogr; 1973 May; 36():123-4. PubMed ID: 4744573
    [No Abstract]   [Full Text] [Related]  

  • 9. Degrees of impairment of cell-mediated immune reactivity in Hodgkin's disease.
    Petrov M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):201-10. PubMed ID: 61913
    [No Abstract]   [Full Text] [Related]  

  • 10. [Assays in delayed hypersensitivity in the course of Hodgkin's disease].
    Bernadou A; Zittoun R; Blanc CM; Smadja R; Bousser J
    Ann Med Interne (Paris); 1970 Mar; 121(3):301-11. PubMed ID: 5507504
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed-type hypersensitivity and the immunology of Hodgkin's disease, with a parallel examination of sarcoidosis.
    Chase MW
    Cancer Res; 1966 Jun; 26(6):1097-120. PubMed ID: 4161706
    [No Abstract]   [Full Text] [Related]  

  • 12. Manifestations of immunologic unresponsiveness in Hodgkin's disease.
    Aisenberg AC
    Cancer Res; 1966 Jun; 26(6):1152-64. PubMed ID: 4161634
    [No Abstract]   [Full Text] [Related]  

  • 13. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current views on the mechanism of immunological disorders in Hodgkin's disease].
    Voĭtenkov BO; Letskiĭ VB; Gavrilenkova LP
    Eksp Onkol; 1984; 6(4):17-22. PubMed ID: 6389087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: Transfer of cell-mediated skin reactivity with "immune" RNA in Hodgkin's disease and other neoplastic diseases.
    Han T
    Cancer; 1974 Feb; 33(2):497-502. PubMed ID: 4130298
    [No Abstract]   [Full Text] [Related]  

  • 16. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects.
    Velardi A; Rambotti P; Cernetti C; Spinozzi F; Bertotto A; Martelli MF
    Thymus; 1983 Sep; 5(5-6):429-32. PubMed ID: 6362105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodeficiencies in Hodgkin's disease. Part I: T cell-mediated immunity.
    Gupta S
    Clin Bull; 1981; 11(2):58-65. PubMed ID: 6459892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Anergy in Hodgkin's disease.
    Ironside P
    N Engl J Med; 1974 Mar; 290(12):691-2. PubMed ID: 4813734
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement in delayed hypersensitivity in Hodgkin's disease with transfer factor: lymphapheresis and cellular immune reactions or normal donors.
    Khan A; Hill JM; MacLellan A; Loeb E; Hill NO; Thaxton S
    Cancer; 1975 Jul; 36(1):86-9. PubMed ID: 1081903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.